Petrina Kamya, Ph.D., is the VP, and Global Head of AI Platforms and President of Insilico Medicine Canada, overseeing Insilico’s end-to-end generative AI-driven drug discovery platform, Pharma.AI. Before joining Insilico, Dr. Kamya's career spanned many key stages of the drug discovery value chain from the early stages to commercialization. She holds a Ph.D. in chemistry and a BS in biochemistry from Concordia University.
Generative AI presents unparalleled opportunities to transform healthcare delivery and outcomes. From personalized treatment plans to drug discovery, the potential impact is immense. Join this panel discussion to
delve into how pioneers in Generative AI for healthcare are approaching, predicting & overcoming challenges in this space.
• Prioritizing data privacy and security measures for patient information.
• Fostering collaboration between healthcare providers and AI experts for innovation.
• Investing in training and recruiting AI talent to drive generative AI initiatives.
Check out the incredible speaker line-up to see who will be joining Petrina.
Download The Latest Agenda